166 related articles for article (PubMed ID: 30994805)
1. Adverse events in patients with leprosy on treatment with thalidomide.
Drummond PLM; Santos RMMD; Carvalho GO; Pádua CAM
Rev Soc Bras Med Trop; 2019 Apr; 52():e20180385. PubMed ID: 30994805
[TBL] [Abstract][Full Text] [Related]
2. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction.
Hebe Petiti-Martin G; Villar-Buill M; de la Hera I; Fuertes L; Burgués-Calderón M; Rivera-Díaz R; Vanaclocha F
Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
Upputuri B; Pallapati MS; Tarwater P; Srikantam A
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
[TBL] [Abstract][Full Text] [Related]
4. Deep venous thrombosis and pulmonary embolism secondary to co-administration of thalidomide and oral corticosteroid in a patient with leprosy.
Yamaguchi S; Yamamoto Y; Hosokawa A; Hagiwara K; Uezato H; Takahashi K
J Dermatol; 2012 Aug; 39(8):711-4. PubMed ID: 22373000
[TBL] [Abstract][Full Text] [Related]
5. The role of thalidomide in the management of erythema nodosum leprosum.
Walker SL; Waters MF; Lockwood DN
Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
[TBL] [Abstract][Full Text] [Related]
6. [Thalidomide used by patients with erythema nodosum leprosum].
Valente Mdo S; Vieira JL
Rev Soc Bras Med Trop; 2010; 43(2):201-4. PubMed ID: 20464154
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
[TBL] [Abstract][Full Text] [Related]
8. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature.
Fabi SG; Hill C; Witherspoon JN; Boone SL; West DP
J Drugs Dermatol; 2009 Aug; 8(8):765-9. PubMed ID: 19663116
[TBL] [Abstract][Full Text] [Related]
9. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy.
Sales AM; de Matos HJ; Nery JA; Duppre NC; Sampaio EP; Sarno EN
Braz J Med Biol Res; 2007 Feb; 40(2):243-8. PubMed ID: 17273661
[TBL] [Abstract][Full Text] [Related]
10. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
11. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
[TBL] [Abstract][Full Text] [Related]
12. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment.
Partida-Sanchez S; Favila-Castillo L; Pedraza-Sanchez S; Gomez-Melgar M; Saul A; Estrada-Parra S; Estrada-Garcia I
Int Arch Allergy Immunol; 1998 May; 116(1):60-6. PubMed ID: 9623511
[TBL] [Abstract][Full Text] [Related]
13. Does thalidomide have a role in leprosy?
Crawford CL
Lancet; 2004 Jun; 363(9424):1911. PubMed ID: 15183644
[No Abstract] [Full Text] [Related]
14. The return of thalidomide: can birth defects be prevented?
Lary JM; Daniel KL; Erickson JD; Roberts HE; Moore CA
Drug Saf; 1999 Sep; 21(3):161-9. PubMed ID: 10487395
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide reconsidered.
Nat Biotechnol; 1997 Oct; 15(10):929. PubMed ID: 9335035
[No Abstract] [Full Text] [Related]
16. The organization, weaknesses, and challenges of the control of thalidomide in Brazil: A review.
Jesus SM; Santana RS; Leite SN
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008329. PubMed ID: 32760161
[TBL] [Abstract][Full Text] [Related]
17. Interventions for erythema nodosum leprosum.
Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of thalidomide for erythema nodosum leprosum (ENL): retrospective study of 20 Japanese cases in National Sanatrium Oku-Komyoen].
Matsuki T; Okano Y; Aoki Y; Ishida Y; Hatano K; Kumano K
Nihon Hansenbyo Gakkai Zasshi; 2014 Dec; 83(3):1-6. PubMed ID: 25826849
[TBL] [Abstract][Full Text] [Related]
19. Elevated platelet counts and thrombocytosis in erythema nodosum leprosum.
Rea TH
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):167-73. PubMed ID: 12483964
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide approved.
Posit Aware; 1998; 9(5):16. PubMed ID: 11365882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
